Position in VRDN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$6,007,540
+$878,342 QoQ
Shares Held
307,134
+86.3% QoQ
Ownership
0.298%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. VRDN ranks #131 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in VRDN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,007,540 | 307,134 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $5,129,198 | 164,820 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $9,660,868 | 447,677 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,460,328 | 533,643 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,796,412 | 504,185 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $9,816,400 | 512,071 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,927,675 | 84,733 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,997,190 | 230,376 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,646,515 | 379,584 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,122,946 | 143,386 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,049,500 | 68,416 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,893,230 | 79,581 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,750,042 | 68,791 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,258,173 | 145,778 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $1,011,081 | 49,297 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $150 | 13 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $4,104 | 222 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $257 | 13 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $23,736 | 1,443 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $237 | 13 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $217 | 13 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||